Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). The studies are expected to begin in January of 2022.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

United Patients Group

OCTOBER 25, 2023

– Topical (Lotions, Balms, or Patches): Ideal for localized pain relief without systemic effects. As the world of medical cannabis continues to evolve, staying up to date on the latest research, legal developments, and medical applications is crucial for informed decision-making.

Marijuana 105

Marijuana Patients Research and Development Edibles 105

Cannabis Law Report

JULY 2, 2021

Research Cluster with expert faculty members from various fields, as well as the first and only Drug Dependence Research Center in the country which is certified by the World Health Organization (WHO) Collaborating Center for Research and Training in Drug Dependence. Find investment partners and move ahead.

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Medicinal Marijuana Association

FEBRUARY 11, 2024

Additionally, CBD has demonstrated anti-seizure properties, making it a potential treatment for epilepsy. Furthermore, ongoing research indicates that CBD might have neuroprotective properties, potentially benefiting individuals with neurological disorders. Is There a Risk of Developing a Tolerance to CBD Over Time?

CBD 52

CBD Research and Development Topical Cannabinoids 52

Cannabis Law Report

JANUARY 18, 2022

Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Well-tolerated with No Serious Adverse Findings. BERWYN, Pa.–(BUSINESS

Safety 52

Safety Chronic Pain Research and Development Pharmaceutical 52

Healer

JUNE 2, 2020

Webinar Research Topics. After years of working in the specialty of pediatric emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. She has a special interest in treating children with intractable epilepsy, autism, and cancer. Play video.

Research and Development 52

Research and Development Epilepsy Topical Education 52

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 4, 2022

Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Wainwright & Co.

Pharmaceutical 52

Pharmaceutical Research and Development Chronic Pain Events 52

MMJ Recs

JUNE 25, 2024

Cannabis consumption for medical purposes has gained widespread acceptance in recent years, thanks to growing research supporting its efficacy in alleviating symptoms associated with numerous medical conditions. One of the key considerations when using cannabis for medical purposes is selecting the appropriate consumption method.

Consumption 52

Consumption Conditions Chronic Pain Tincture 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Key Topics Covered: Chapter 1 Methodology and Scope. Research Methodology. Research Scope And Assumptions. Market Segmentation and Scope.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

MMJ Recs

JUNE 9, 2024

Qualifying conditions include chronic or debilitating diseases, including cancer, epilepsy, multiple sclerosis, Crohn’s disease, Parkinson’s disease, and post-traumatic stress disorder (PTSD), among others.

Access 52

Access Marijuana Patients Programs 52

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Since the early 1990s, Israel has stood at the front line of cannabis medicalization.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MMJ Recs

FEBRUARY 3, 2021

CBD has been used for relief of conditions such as: Seizures disorders and epilepsy Chronic inflammation Chronic pain Psychosis or mental health disorders including anxiety and depression Nausea Migraine headaches Gastrointestinal disorders such as inflammatory bowel disease. One particular study also gave participants stress tests.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

NOVEMBER 10, 2021

You can find a great post to read on the said topic from company sites like Buena Vida Botanicals. But, if you have a medical condition, such as heart issues, kidney disease, epilepsy, or a weakened immune system due to cancer, avoid taking CBD oil without a doctor’s consultation. May Cause Injury To The Liver.

Oil 52

Oil CBD Research and Development Chronic Pain 52

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Alchimia

JUNE 20, 2016

An important point to highlight is the study recently published on the Cannabis and Cannabinoid Research website (June 2016) which shows that orally taken CBD may turn into THC due to the action of the digestive juices in the stomach. CBD Crew has recently developed a strain – named CBD Therapy – with much more CBD than THC.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

MMJ Recs

MARCH 14, 2024

These conditions include, but are not limited to, cancer, epilepsy, multiple sclerosis, and PTSD, among others. West Virginia’s Medical Marijuana Program Updates and Future Developments West Virginia’s medical marijuana program is continuously evolving with updates and future developments.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

PrestoDoctor

OCTOBER 13, 2023

Initially developed in the 1980s, Marinol was primarily used to alleviate symptoms associated with chemotherapy-induced nausea and vomiting. More research is necessary to fully understand its efficacy in different pain management scenarios. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Otherside Farms

JANUARY 17, 2020

The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. Many use vapes while others use topical creams for the treatment of injuries; others use CBD oils and hemp leaves in their recipes as food ingredients. So, how does cannabis affect eating lifestyles?

Food 52

Food Research and Development Seed-To-Sale Vaping 52

Cannabis Law Report

JANUARY 6, 2020

The ongoing studies and research that focuses on CBD provide a very clear picture of how this compound can provide some health benefits relating to seizures, cancer, anxiety, pain, and inflammation. Some research studies have linked the endocannabinoid system has to the pathogenesis of autism. taking a dose. Reduce inflammation.

Oil 59

Oil CBD Sleep Research and Development 59

The Joint Blog

JANUARY 20, 2021

In recent years, as more research and studies have been undertaken on the subject of marijuana, a range of new benefits have been discovered. In patients with epilepsy, Alzheimer’s, chronic pain conditions, and more, marijuana can once again be used. Cannabis and Benefits.

Marijuana 68

Marijuana Sleep Chronic Pain Research and Development 68

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

FEBRUARY 3, 2022

Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. CBD oils have various health benefits in treating medical disorders like epilepsy, anxiety, cancer, acne, diabetes, and others. Product Development Via Research and Novel Product Delivery Solutions. Opportunities.

Indica 52

Indica Oil Legalization Clinical Trials 52

Healer

JANUARY 17, 2022

More recently, breeders have developed varieties of cannabis that lack the enzymes responsible for converting CBGA into the other cannabinoids, resulting in fully mature flowers dominant in CBGA and low in THC and other cannabinoids. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development CBD 52

Healer

JANUARY 17, 2022

More recently, breeders have developed varieties of cannabis that lack the enzymes responsible for converting CBGA into the other cannabinoids, resulting in fully mature flowers dominant in CBGA and low in THC and other cannabinoids. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

MMJ Recs

MAY 29, 2024

Medical cannabis offers a promising alternative, with research indicating its efficacy in alleviating a wide range of symptoms associated with various medical conditions. The importance of access to medical marijuana for individuals with qualifying medical conditions cannot be overstated. You can find an approved physician here.

Marijuana 52

Marijuana Programs Patients Conditions 52

The Joint Blog

SEPTEMBER 17, 2020

It is hard to measure anxiety, but researchers have been able to confirm this CBD benefit with hard science. Researchers found test subjects that were afraid of public speaking, treated them with 600mg of CBD oil, and had them give a public speech. This study might be interesting, as it proved the anxiety-reducing benefits of CBD.

Oil 26

Oil CBD Blood Pressure Research and Development 26

Kind Meds (Cannabis Education Blog)

AUGUST 16, 2021

Everyone remembers the news story about the remarkable transformation of children with severe epilepsy , where their seizures were dramatically reduced or eliminated by just a little bit of cannabis tincture. Researchers continue to study CBD’s short-term neuroprotective effects in the brain for possible treatment of sports concussions.

Marijuana 111

Marijuana Chronic Pain Tincture Cannabinoids 111

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 83

Research and Development Oil Cannabis Clinical Trials 83

The Joint Blog

AUGUST 31, 2019

CBD is a hot topic among health practitioners and advocates for hemp. While the benefits of CBD are still drawing a lot of debate, there are a lot of discoveries by scientists and researchers. This way, it helps protect the nervous system and prevent the development of degenerative diseases. What Are The Benefits Of CBD Vaping?

Vaping 34

Vaping CBD Blood Pressure Research and Development 34

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. This process should also ensure appropriate funding allocated for this research.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40